Gene · 29116
MYLIP: myosin regulatory light chain interacting protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MYLIP: myosin regulatory light chain interacting protein. Genes, record 29116. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/29116
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8WY64 | E3 ubiquitin-protein ligase MYLIP | 445 | 35 | Ensembl, GeneID, HGNC |
Source UniProt
Patents22
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 54635 | Q8WY64 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7355 | Q8WY64 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5259 | Q8WY64 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7355 | Q8WY64 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 31957 | Q8WY64 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5259 | Q8WY64 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 31957 | Q8WY64 | Espacenet |
| KR 1020230125856 A | 2023-08-29 | 1804 | Q8WY64 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 31957 | Q8WY64 | Espacenet |
| JP 2023510565 A | 2023-03-14 | 67 | Q8WY64 | Espacenet |
1 to 10 of 22
See all 22 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,014
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MYLIP papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| ZIAHL006001 | Framingham Project/Levy | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 3 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30ES019776 | HERCULES: Exposome Research Center | 3 | 2025 |
| P50CA127001 | SPORE in Brain Cancer | 3 | 2025 |
1 to 10 of 1,014Source NIH's project files
See all 1,014 nih grantsPapers1,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The E3 ubiquitin ligase IDOL suppresses PRRSV replication by targeting viral Nsp3 for SQSTM1-mediated selective autophagic degradation. | mBio | 2026 | 42742217 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify an RXR-MYLIP-LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas. | Oncogene | 2026 | 42642488 | PubTator, text mining | PubMed |
| MYLIP-dependent ubiquitination and degradation of LDLR in acute myeloid leukemia and MAPK signaling. | Mol Cell Probes | 2026 | 42235836 | PubTator, text mining | PubMed |
| Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis. | Asia Pac J Clin Oncol | 2026 | 41942838 | PubTator, text mining | PubMed |
| LncRNA SNHG25 promotes proliferation, migration, and invasion of acute myeloid leukemia by competitively binding to miR-205-5p. | Clin Exp Med | 2026 | 41865170 | PubTator, text mining | PubMed |
| Functional interrogation of candidate cis-regulatory elements at the LDLR locus. | PLoS Genet | 2026 | 41843552 | PubTator, text mining | PubMed |
| Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products. | Sci Rep | 2026 | 41826414 | PubTator, text mining | PubMed |
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| PCSK9-mediated degradation of cell-surface LDL receptors impairs human CD8+ T cell effector functions. | iScience | 2026 | 41767258 | PubTator, text mining | PubMed |
| Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4. | Int J Mol Sci | 2026 | 41751849 | PubTator, text mining | PubMed |
1 to 10 of 1,569
See all 1,569 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/29116
GET https://conductscience.org/api/genes/v1/29116/patents?page=2